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The Search for an Explanation: Breast Cancer in the Context 
of Genetic Inheritance 
 
Christine Maheu 
University of British Columbia, Vancouver, Canada 
 
This case study is an in-depth examination of how Erika (a pseudonym) 
interpreted and understood her genetic test results for breast cancer 
susceptibility. Her experience is presented in the form of a biography, 
which was built from key passages retrieved from the semi structured 
interview the author conducted at Erika’s home. The interview data 
showed that Erika’s interpretation and understanding of her inconclusive 
test results were embedded in her own and her family’s experiences with 
breast cancer. Her interpretation of her test results was influenced by 
perception of risk for future breast cancers for herself and her family, as 
well as from the continued etiological uncertainty of her current breast 
cancer. Although unfinished, Erika’s experience of receiving inconclusive 
genetic test results for breast cancer susceptibility provides examples of 
possible universal themes within the experience of others who receive 
similar test results. Key Words: Breast Cancer, Genetic Testing, Life 
Experience, Inconclusive, and Qualitative Research
 
 
Introduction 
 
 The findings presented here are part of a doctoral dissertation that looked at how 
women interpreted and understood their inconclusive genetic test results for breast cancer 
susceptibility. Many of the participants in the study explained how they looked to genetic 
testing to explain their breast cancer diagnosis and their family history with the disease. 
Their journey of learning to live with cancer led many to seek answers from genetic 
testing. As the participants went through the experience of genetic testing, one of their 
biggest challenges came when they received what was termed by their testing agency as 
inconclusive test results. Other studies have documented that receiving an inconclusive 
result from testing for breast cancer susceptibility is common. In fact, the majority (75% 
or more) of individuals at high risk for breast cancer because of a past diagnosis and 
significant family history with the disease test inconclusive (Schwartz et al., 2004; 
Schwartz, Peshkin, Hughes, Main, Isaacs, & Lerman, 2002; van Dijk et al., 2005). 
Because of these risk factors, an inconclusive result means that the absence of an 
inherited gene mutation (which may result in cancer) remains unconfirmed (Gritz et al., 
2005).  
 Now that genetic testing for adult-onset hereditary disease has become an 
important part of clinical genetics practice, there is an increased demand for these tests. It 
is likely to continue as a result of media coverage of genetic discoveries. To date, very 
few studies have addressed how inconclusive breast cancer genetic test results are 
Christine Maheu  130 
 
understood outside the clinic by individuals who receive them. Understanding how 
inconclusive results can be interpreted by laypeople was one of the aims of this study. 
 
Background 
 In genetic testing, BRCA1 and BRCA2 are the two most common breast and 
ovarian cancer genes tested to determine inherited susceptibility to these diseases. BR 
stands for breast and CA for cancer, while 1 and 2 represent the order in which the genes 
were discovered in the mid-1990s (Gritz et al., 2005). Mutations on either the BRCA1 or 
BRCA2 (BRCA1/2) gene predisposes individuals to breast and ovarian cancers. In some 
families, there is a cluster of only breast cancers, in other families only ovarian cancers, 
and, in still others, both. All individuals carry these two genes, which, when not mutated, 
protect against the development of cancer. They suppress tumours by regulating DNA 
damage and maintaining genomic1 stability. 
 Genetic testing of BRCA1/2 is usually reserved for individuals with a past breast 
cancer diagnosis who also have a family history of cancer indicative of a possible 
inherited mutation. A significant family history of breast and ovarian cancer represents 
having multiple cases of cancer on the same side of the family, with some cancer 
diagnoses occurring at an earlier age than expected in the general population. When an 
individual with a past breast cancer diagnosis undergoes genetic testing for BRCA1/2, 
there are three possible results. First, a mutation can be found in either gene. This is 
called a positive result. It means that the person’s lifetime risk of breast cancer is between 
56% to 87%, and their lifetime risk of ovarian cancer 16% to 40% (Di Prospero et al., 
2001). Children of individuals carrying an inherited mutation have a 50% chance of 
inheriting the mutation. The second possible result is that the person is told that she does 
not carry the inherited mutation previously identified in one of her relatives. This is 
called a true-negative result. It means that her risk depends on her family’s cancer 
history. The third possibility is an inconclusive result. This means that, although no 
mutation was found in either BRCA1 or 2, because of the person’s personal and family 
history with breast cancer, it is impossible to confirm that she does not carry an inherited 
mutation or that her breast cancer may have occurred by chance; hence the term 
inconclusive. The risk for these people of developing breast and/or ovarian cancer 
depends on their personal and family cancer history. 
 A family history of breast cancer is recognized as one of the most important risk 
factors for the disease (Yang & Lippman, 1999). Although only a few studies exist on the 
percentage of those who are likely to receive inconclusive results from their BRCA1/2 
genetic tests (Schwartz et al., 2002, Schwartz et al., 2004; van Dijk et al., 2005), Peshkin, 
DeMarco, Brogan, Lerman, and Isaacs (2001) estimate that 16% to 66% of all families 
considered at risk of breast cancer do not carry detectable mutations in these two cancer 
genes. Considering the growing interest in genetic testing for BRCA1/2, especially 
among individuals with a family history of cancer, we can expect to see a growing pool 
of individuals who are likely to receive unclear test results, such as inconclusive. Thus, 
genetic counselors and other health professionals face many challenges, such as how to 
properly support individuals in making health-related decisions with uncertain 
information, how to guide these individuals in communicating uncertain test results to 
                                                 
1 Gene plus chromosome. 
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family members and, most important, how to live with continued uncertainty about their 
possible risk of carrying an inherited gene mutation. To answer these questions, there is 
need to document the interpretation and understanding of individuals who received 
inconclusive results to an inherited susceptibility of breast cancer.  
 In this paper I illustrate how one participant, Erika, interpreted and understood her 
test results for breast cancer susceptibility in the context of her everyday health and 
illness experiences. Before being eligible for BRCA1/2 testing, Erika had to meet specific 
criteria; her risk of carrying an inherited mutation had to be above that of the general 
population. First, Erika was diagnosed with breast cancer at the early age of 35 years old. 
Second, she had multiple relatives diagnosed with breast cancer. Her maternal 
grandmother was diagnosed with breast cancer at 50, and her maternal grandaunt was 
diagnosed at 70. She had a maternal aunt who was diagnosed with two primary breast 
cancers, one at 40 and the other at 45. All of these relatives died of the disease. Despite 
this significant personal and family history of breast cancer, after genetic testing Erika 
was told that no mutation in her BRCA1 and BRCA2 cancer genes had been found. 
However, because of her personal and significant family history of breast cancer, the 
clinic could not conclude with certainty that she did not have an inherited mutation.  
Along with her inconclusive test results, Erika was given a letter describing four 
possible interpretations of inconclusive test results: (a) a mutation may exist in the region 
of the BRCA1 or BRCA2 gene that the lab looked at, but it was not detected by the 
current testing method; (b) a mutation may be present in the untested portion of the 
BRCA2 gene (only 72% of the BRCA2 gene was tested examining only areas where 
most mutations of clinical relevance had appeared thus far); (c) the mutation responsible 
for their cancer may be in another, as-yet-unidentified, hereditary cancer gene; or, (d) the 
woman does not have an inherited breast/ovarian cancer gene mutation, which means that 
her cancer may have occurred by chance. Erika was also told that the inconclusive test 
results did not mean that an inherited breast cancer gene mutation in their family was 
completely ruled out. Thus, she remained at increased risk for breast cancer.  
 
Aim of Study 
The aim of this case study was to examine in depth one woman’s experience of 
receiving inconclusive test results for breast cancer susceptibility. Her experience is 
presented in the form of a biographical interpretation (Denzin, 1989). Using a graphic 
illustration (Figure 1), I present how Erika interpreted and understood her test results. 
The illustration and therefore the interpretation of Erika’s experience was built using key 
passages retrieved from her interview.  
 
Method 
 The theoretical foundation of this study was the biographical interpretive method, 
described by Denzin (1989) within his interpretive interactionism approach. The 
biographical interpretive method provides understanding of the existential, interactional, 
and life-history aspects of lived experiences. Analyzing interactional text highlights how 
the individual’s world and the clinical context connect to form an existential experience 
(Denzin). Biographical interpretation focuses on how the individual experienced and 
Christine Maheu  132 
 
understood the event, and how it was filtered through the multiple spheres of her life. 
Thus, this method is well suited to case studies. Further, lived experiences presented in 
the forms of narratives and artistic displays represent a method of knowing referred as 
evocative experimental writing and as creative analytical processes (Richardson & St. 
Pierre, 2006). Richardson and St. Pierre view creative analytical processes as new forms 
of social representations drawing from literary, artistic, and scientific genres. In this text, 
Erika’s narrative is presented in a creative analytical process with the purpose to evoke a 
relationship between the text and the case study presented.  
 
Data collection 
 
The key experiences presented in the biographical interpretation were gathered 
during a semi-structured interview. I conducted the interview in Erika’s home, rather than 
in the genetic testing clinic. I chose the home to elicit everyday discourse and to 
encourage Erika to explain how she interpreted and understood her inconclusive results, 
rather than the medical jargon of the clinic. The interview lasted 90 minutes. After the 90 
minute period, Erika felt that she had shared as much as she was willing to. She described 
her interview experience as the beginning of the end of her genetic testing experience. 
She expressed at this point that I need to move on. Reflective of Leininger’s (1994) 
explanation of saturation, Erika felt that she had provided an exhaustive exploration of 
her experienced as lived. The interview was transcribed verbatim on the same day. Field 
notes written immediately following the interview facilitated the recognition of potential 
beliefs and perceptions in relation to the meanings attached to her making sense process. 
The interview transcript was transferred into QSR N5™ software for data management 
and to facilitate the inductive analytic process. Clearance to conduct the study was 
obtained from the Behavioural Research Ethics Boards of both the hosting institution and 
of the recruiting agency.  
 
Data analysis 
The interpretive interactionism approach rests on the analysis of stories about 
turning points in people’s lives. Depending on the focus of the interaction, the teller talks 
about events that are significant to both him/her and his/her audience. The role of the 
researcher is to locate the teller’s self in the story and to write a biography of the 
individual that incorporates the teller’s experience and the context in which the 
experience takes place. In doing so, the researcher identifies important parts of the story 
that speaks to the phenomenon studied and interprets them as an informed reader. 
Throughout this work, the researcher attempts to contrast emerging interpretations with 
evolving hypotheses from parts of the text already interpreted. When the researcher has 
finished the analysis, she presents it in the form of a unified narrative.  
Validity of findings in interpretive studies is defined in their potential to create 
mental heuristics that confirm hunches of expert clinicians from the field studied where 
they would see new understandings of their reflective practice observations (Thorne, 
Reimer Kirkham, & O'Flynn-Magee, 2004; Thorne, Reimer Kirkham, & MacDonald-
Emes, 1997). Hence, I sought feedback from expert clinicians within genetics throughout 
my data analysis in peer-reviewed scientific presentations and nursing rounds at two 
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different universities. The feedback I received encouraged me to refine my data analysis 
for clarity and depth of analysis. Field notes and journaling also facilitated the evolution 
of my reflection during data analysis and led me to question my early assumptions about 
participants’ experiences. One such assumption was presuming that individuals who 
received a genetic test would automatically want to tell family members. In the course of 
the interview, it became apparent that such an assumption did not hold true for the Erika. 
Hence, I shared this assumption with her. She explained that in light of her genetic 
results, there was no need to worry others at this time. This dialectical approach created 
space to clarify the meanings Erika brought to her results and allowed in-depth 
understanding of her experience of receiving inconclusive test results for breast cancer 
susceptibility. One such understanding was that genetic testing came to play a very small 
part in her everyday life compared to more stressful events such as her breast cancer 
experience. Another component critical to interpretive studies is explicit accounting of 
researcher’s biases that may influence his/her study. One such bias is a belief that we, as 
health professionals, often interpret clinical tests and results differently than our patients 
do. Consequently, although I interpret the genetic test results that Erika received as 
inconclusive (meaning that no conclusion can be drawn from her results), in the 
interviews I referred to her results just as “your genetic test results.” I tried not to 
influence her interpretations of her results by not showing approval or disapproval of her 
interpretation. 
 
Results 
Figure 1 presents the basic units of Erika’s story about how she interpreted and 
understood her genetic test results. As Denzin (1989) instructs, the life of the storyteller 
must always be in the forefront of the interpretation. The research process and structure 
must blend with the storyteller’s experiences in order to not lose sight of the individual 
studied.  
 
Figure 1. Erika’s interpretive framework of her experience with receiving inconclusive 
genetic results for breast cancer susceptibility. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Erika: “I was looking for an explanation, but at the same time I did 
not want to hear that I had the gene.”
Then what? 
Why did I have breast 
cancer ?
Looking for an 
answer, for a fault
Got no answer with 
genetic testing
(1 1 9 2 )
Not genetic
Feels good to tell 
husband & sisters: 
“I don’t have the gene.”
“Feels good because I can 
control the environment 
but not if I had the gene.”
What to control and how?
Internal factors - lifestyle 
External factors
Similar and different external
environments
Environmental ?
Not passing down 
to daughter
(1 2 0 1 ) (1 2 5 2 -1 2 5 4 )
(1 2 8 7 )
(1 7 2 4 )
(1 7 6 4 )
(1 1 8 9 )
(1 1 9 0 )
(1 3 3 2 -1 3 3 4 )
(1 1 9 2 )
(1 6 2 6 -1 6 2 7 )
(7 7 1 -7 7 3 )
(1 2 7 5 )
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The title for Figure 1 was taken from a passage in Erika’s interview: “I was looking for 
an explanation for my breast cancer, but at the same time I didn’t want to hear that I had 
the gene.” This statement reflected Erika’s need to find the etiology of her breast cancer 
diagnosis. In her interview, she referred to having a mutation as “having the gene.” Next 
are interview excerpts that expand on key passages presented in Erika’s interpretive 
framework found in Figure 1. The numbers in brackets represent positions in the 
interview where the key passages were retrieved. The interview excerpts are rewritten 
statements of Erika’s experience. They represent a thick description and interpretation of 
her lived experience. Thick description, as opposed to thin description that simply states 
facts, provides the context of the phenomenon explored, uncovers meanings that organise 
experiences, and traces the phenomenon’s evolution. Thick description presents 
meanings and feelings as a text that can be interpreted (Denzin, 1989). 
 
“Why did I have breast cancer?” (1192) 
 
You know, that is the big question. Why did I get it? Why did I get breast 
cancer in the first place? Was it environmental or diet? And if there is a 
family history and I do not have the gene, then how is it passed on? So at 
the time I thought, Okay, did I do something, like my karma, you know? 
You are reaching for anything, anything that will give you an answer. So, 
in that respect, a positive genetic-test result would have been like, Okay, 
no, it was not my fault (1724). It was just there, and it just happened. But 
no, my genetic testing did not give me that answer, or no answer (1764).  
 
“I am not passing the gene to my daughter.” (1189) 
 
But now I am glad that my breast cancer is not genetic or inherited (1189). 
I wanted ways to sort of, hopefully, do the best I could possibly to help 
prevent breast cancer from happening to my daughter (1190). At least by 
not having the gene, there is a possibility that I might have some control 
over breast cancer from happening to me again, or to my family. But if 
you have the gene, it is like you lose all preventive control (771-773). But 
now, with my inconclusive results, it feels there are no answers yet if it is 
completely environmental or genetic. But then, if I do not have those 
genes, why did I get breast cancer? In some ways, it would have almost 
have been better to say, Okay, you have got the gene, that is why you got 
breast cancer. But, at the same time, it feels good to be able to say, Oh, I 
do not have that gene. It feels good to be able to tell my husband, Oh, you 
know, I got the results, and I do not have the gene. And it feels great to be 
able to tell my sisters that, too (1332-1334). You know, I can't control 
whether I have this gene or not, but perhaps, through diet and exercise, I 
can better control my environment. And that maybe my daughter can, you 
know, perhaps control how the environment can affect her risk of breast 
cancer and, or maybe, maybe, how the gene might mutate or not with the 
environment. So I was just trying to find out. So it is mostly for my 
daughter. And I also wanted the information in terms of my sisters. 
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“If not genetic, then why did I get breast cancer?” (1192) 
 
Then why did I get it? Why did I get cancer in the first place? Was it 
environmental? Sometimes, is it environmental? If I cannot figure out if it 
is environmental or not, then how am I suppose to know what to control 
(1626-1627)? Because from where I grew up, there was this huge pulp 
mill, and they were producing this chemical and blowing out these fumes. 
And, an interesting thing happened when I was receiving my treatment at 
the clinic. I was there one day, and my sister was with me, and this woman 
came out of the washroom as I was about to go in. And I looked at her, 
and I thought I recognized her. And I said, ‘Vivian!’ And it was a girl that 
I was really good friends with in high school. And we had sort of lost 
touch over the years as we went on to university and what not. And now, 
she had breast cancer in the same breast, in almost the same location and 
the same size of tumour as me. She was just about 3 months behind me in 
terms of her treatments. I think she was just starting her treatments. And I 
was actually doing my radiation, and she was just starting her chemo. You 
know, we both grew up in the same city. And I just thought, I do not 
know, am I reaching for straws or something? But it is just a thought. Is 
there some sort of connection there that we both happened to get it at the 
same time, same age? You know, it is the same kind of circumstances. 
 
External factors (1201, 1252-1254) 
 
I do not know if there is an explanation there, because my sisters, they are 
both past 35. And they have not, to their knowledge, developed anything, 
and they grew up in the same environment as me. Ya, 35 years old was 
sort of the number, you know, that is when I was diagnosed with my 
breast cancer.  
 
Lifestyle (1287) 
 
It is just that you want to be able to feel like you can do something. I do 
not know what I can do. Maybe it is as simple as lifestyle. I am always 
thinking that maybe I should not be eating that. Can I do this? Am I being 
diligent enough? Am I just inviting this cancer back by not doing this or 
that? And there are so many conflicting reports. I mean, I want the 
information, I want to know. But, at the same time, I went through a whole 
period there where I did not want to eat anything. And I went through a 
phase where it was, like, click, I turned off. I did not want to read or hear 
of anything anymore of breast cancer. I had had enough. And, besides, I 
could not even process the information anymore. It was almost as if it was 
too much. I do not know what to do with the information, because there 
are so many studies being done. And one study says, uh, oh caffeine is bad 
for you if you have cysts and breast cancer. And it was even in Susan 
Love’s book on breast cancer that she said you can have that extra cup of 
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coffee and the link to that, between caffeine and fibrocystic breast disease, 
is nonexistent. And then 2 years ago, I was going to my family 
practitioner, and she felt some lumps. She said, ‘I really do not think you 
should have caffeine anymore.’ So I gave up caffeine. But you know what 
I mean, it is like, Okay, what did I do? And I think about the lifestyle, too, 
and the quality of life, too. I cannot cut off everything. So then, if I do not 
know in the first place what caused my breast cancer, how can I know that 
I am not continuously exposing myself to risk factors that may yet produce 
another cancer? 
 
Then What? (1275) 
 
Researcher (R) speaking to Erika (E):  
R: So, although you have had these results, do you still feel that maybe 
there is a mutation in your family?  
E: Well, I wonder. I mean, there is breast cancer in the last three family 
generations. 
R: So, then, do you make any more sense of your results other than you do 
not have the gene, and therefore you are not passing down the mutation to 
your daughter?  
E: No, Not really, I guess I am still waiting to see, to see what the next set 
of tests will bring. I am waiting to see. For now, it is somewhat of a relief 
to know that no gene for my breast cancer was found. 
 
Discussion 
Erika shared that she did feel relief after receiving her genetic test results: she 
perceived that her breast cancer did not result from an inherited genetic mutation and 
that, therefore, her daughter is probably not at risk of such a mutation. But Erika did not, 
however, get relief from her worry about her breast cancer’s etiology. She still wondered 
whether her cancer came from her family history with the disease or was caused by 
exposure to an environmental toxin. She decided that, until further gene discoveries are 
available, she would not interpret her results beyond concluding that she was not found to 
carry the “gene” (in her words).  
Erika stated twice that she was looking for an explanation to her breast cancer 
diagnosis but was hoping not to hear that it was the result of a genetic mutation. In this 
statement, there is a notion of continuous uncertainty that individuals must learn to live 
with when they receive inconclusive results of breast cancer susceptibility testing. 
According to a theory of uncertainty by Mishel (1988, 1990, 1997), living with 
uncertainty can lead to distress. For this reason, educational materials and clinical support 
would be helpful to individuals who receive inconclusive test results. Psycho-social 
support in the form of written material and in providing open communication with a 
health professional helps in reducing uncertainty (Mishel, 1988; Stiegelis et al., 2004). It 
does so by providing assurance of the stability of the environment that individuals 
participated in, in this case having preceded to genetic testing services. An example in 
providing an open communication could be a onetime follow-up telephone call.  
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This case study highlights the conflictual, contradictory nature of lived 
experiences and how they can influence individuals’ understanding of medical events. 
The case study also shows that no single interpretation can ever fully capture a 
problematic event and that the interpretation of problematic events is never complete. 
Just as Denzin (1989) explains, interpretations from biographical analysis, although 
unfinished, provide examples of universal themes that can structure the moment in 
history being studied. This means that health professionals and genetic counselors need to 
be aware that multiple interpretations may exist of the experience of receiving 
inconclusive genetic test results for breast cancer susceptibility. They must also 
remember that these interpretations evolve as recipients’ lives do.  
From this perspective, recommendation for clinical practice would be to 
continually assess individuals’ experience of genetic testing. The evolving context and 
possibilities of genetics is likely to prompt change in how individuals will make sense of 
their inconclusive results. Further recommendation is for the use of biographical 
interpretation to capture individual and aggregate experiences of genetic testing. It is my 
belief that, by studying and interpreting people’s experiences with genetic test results, 
better understanding of their personal struggles will be possible. Ongoing study of many 
individuals’ experiences will reveal commonalities and differences. The resulting 
aggregate knowledge will illuminate variations within the process of making sense of 
inconclusive results. Knowledge of the aggregate experience and its variations will then 
help us to better counsel each individual and family we meet. By comparing and 
contrasting individuals’ specific experience to aggregate experience provides opportunity 
to normalize the experience. This approach of providing social comparison information 
has been successful in past studies in reducing uncertainty (Stiegelis et al., 2004).  
In conclusion, this case study highlights the inner struggles individuals with 
personal and family histories of breast cancer must face after they receive inconclusive 
genetic test results. The study points to a need: to evaluate, with our clients, their lived 
experience of having personal and family cancer histories and its impact on the 
understanding of genetics and genetic inheritance.  
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